iridium radioisotopes has been researched along with Kidney Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gabor, S; Hackl, A; Mayer, R; Prettenhofer, U; Stranzl, H; Wurzinger, G | 1 |
| Crim, C; Harrison, BR; Hyers, TM; Marshall, SJ; McDonald, RD; Naunheim, KS; Ohar, JA; Raju, PI; Roy, T | 1 |
| Dauplat, J; Fondrinier, E; Kauffmann, P; Le Bouedec, G | 1 |
3 other study(ies) available for iridium radioisotopes and Kidney Neoplasms
| Article | Year |
|---|---|
Fractionated intraluminal HDR 192Ir brachytherapy as palliative treatment in patients with endobronchial metastases from non-bronchogenic primaries.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Breast Neoplasms; Bronchial Neoplasms; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Dose Fractionation, Radiation; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Kidney Neoplasms; Male; Middle Aged; Palliative Care; Prostatic Neoplasms; Radiotherapy Dosage; Rectal Neoplasms; Sigmoid Neoplasms; Time Factors; Tongue Neoplasms; Tonsillar Neoplasms; Urinary Bladder Neoplasms; Uterine Neoplasms | 2002 |
IR-192, low dose rate endobronchial brachytherapy in the treatment of malignant airway obstruction.
Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Brachytherapy; Carcinoma, Renal Cell; Female; Humans; Iridium Radioisotopes; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy Dosage; Survival Rate | 1993 |
Intracholedocal metastatic thrombus of renal adenocarcinoma.
Topics: Aged; Brachytherapy; Carcinoma, Renal Cell; Common Bile Duct Neoplasms; Humans; Iridium Radioisotopes; Kidney Neoplasms; Liver Neoplasms; Male; Nephrectomy; Thrombosis | 1992 |